Every year, global leaders, CEOs, investors, and multilateral bodies from across the world gather in Davos for the World Economic Forum (WEF) Annual Meeting.
It’s one of the few moments when political power, capital, and policy thinking sit in the same room to shape how the world responds to what comes next.
This year, the 56th World Economic Forum Annual Meeting, Davos 2026, took place from January 19–23 under the theme “A Spirit of Dialogue.”
More than 60 heads of state and government (Presidents and Prime Ministers), alongside a record 400+ political leaders, and over 830 CEOs and Chairs, came together to discuss the issues defining this decade.
From healthcare and economic uncertainty to geopolitics, climate, and financial resilience, these conversations were heavy. And they will influence policy decisions, funding flows, and how systems evolve across countries this year.
In this piece, we focus on what stood out for health at Davos 2026, and what it signals for the road ahead.
From “Digital Health” to “Health Intelligence”
In a World Economic Forum 2026 White Paper, WEF positioned Abu Dhabi as a global pioneer in Health Intelligence, moving healthcare from digital records to predictive, system-level intelligence.
With enormous amounts of health data being generated, we can no longer run on fragmented apps and siloed systems. We need unified intelligence where clinical, genomic, financial, and environmental data work together as one system.
And Abu Dhabi’s model offered proof at scale.
Abu Dhabi’s health infrastructure now connects over 3,000 healthcare facilities and more than 3.5 billion clinical records, reducing heart attack response times by 30%.
In 2026, scaling healthcare means building system-wide intelligence. The one where data anticipates crises before they unfold.
The rise of “Agentic” healthcare
One theme that recurred across Radio Davos sessions and the Reimagining Healthcare panels was: AI is evolving.
Healthcare AI is moving beyond chatbots and copilots into agentic systems. AI that can plan, execute, and manage multi-step workflows with minimal human intervention.
That includes faster clinical documentation, smarter triage, operational logistics, and administrative decision-making. All without constant prompts.
Alex Karp, CEO of Palantir, framed these systems as essential for transparency and efficiency, particularly in public administration and healthcare, where processing delays can cost both time and lives.
Healthtech is transitioning from “digitising paperwork” to “digitising the actual work.”
Longevity and value-based care become mainstream
Discussions focused on how traditional healthcare expenditure is no longer sustainable for ageing populations.
There was a renewed push toward Value-Based Health Care (VBHC), where funding is tied to patient outcomes rather than volume of procedures.
Elon Musk added fuel to the conversation, forecasting a future where ageing can be reversed, and humanoid robotics can help address caregiving labour shortages.
Longevity, once framed as a wellness trend, was being discussed as a core economic strategy. Maintaining a healthy, productive population is essential for labour stability and fiscal resilience.
Global health equity is a strategic advantage
WHO Director-General Dr. Tedros Adhanom Ghebreyesus delivered a powerful address, warning that the so-called “golden age” of global health funding has cooled. But instead of framing this as a setback, he positioned it as an opportunity for self-reliance.
Emerging economies like Ethiopia, Zimbabwe, and Zambia are already replacing siloed, disease-specific digital platforms with interoperable national health architectures.
Governments and investors must now align around national AI and data systems that can serve multiple health priorities at once.
NCDs are systems failure, not a clinical one
Non-communicable diseases (NCDs) such as cardiovascular disease, cancer, and diabetes account for nearly 75% of global deaths, yet they remain under-prioritised in the global health agenda.
Mosa Moshabela, Vice-Chancellor and Principal of the University of Cape Town, called out this gap. He noted that between 2011 and 2030, the world is expected to spend more than $30 trillion to tackle NCDs.
The problem is not just cost, but direction. Instead of absorbing treatment expenses, health systems can invest more of it in prevention.
Johan Westman (AAK) argued that addressing NCDs requires aligning food companies, policymakers, and health guidelines so that healthier choices become the default, not the exception.
Shamsheer Vayalil (Burjeel Holdings) further added the importance of addressing them across schools, communities, and daily life.
Reducing the NCD burden will not come from hospitals alone. It will require coordinated action across food systems, urban design, education, and labour—far beyond the clinic walls.
An icy funding climate and a shift in capital
While PE and VC funding dropped in 2025, Davos 2026 signaled Sovereign Wealth Funds stepping in to fill the gap, particularly in life sciences and deeptech.
Capital is swinging away from purely software plays toward “Digital-Physical Integration”. This includes semiconductors, specialised medical data centers, and biotech-led growth.
Kerala (India) and other regional powers showcased their growing biotech and genomics ecosystems.
This signals that the next wave of healthtech growth may come from places that can co-locate manufacturing, data, and digital innovation.
WHO’s 2026 reality check
Dr Tedros was blunt. The era of large-scale global health aid is ending.
With funding freezes and stalled progress, WHO called for a decisive pivot. Nations must move from aid dependency to strategic self-reliance.
The immediate priority is finalising the Pandemic Agreement by May 2026. Its core is the PABS system that’ll give countries that share dangerous new pathogen samples a guaranteed equitable access to resulting vaccines and treatments.
To fund this new reality, WHO also advocated for “health taxes” on products like tobacco and sugary drinks, creating permanent revenue for health systems.
Despite global divisions, global health is a rare area where all 194 nations can still find common ground.
Health must be a right for all, not a privilege for some.
Healthcare at a tipping point
The At the Cusp of Healthcare for All session captured the mood of Davos health conversations.
The panel included Bill Gates (Bill & Melinda Gates Foundation), Paula Ingabire (Rwanda’s Minister of ICT and Innovation), and Peter Sands (Executive Director, The Global Fund).
They focused on how AI, data, and connectivity can dramatically expand access in low- and middle-income countries, if paired with the right infrastructure and policy support.
Gates noted that “developing world health may even get ahead of rich countries,” driven by urgency and fewer legacy constraints.
But the panel emphasises how technology alone doesn’t transform healthcare.
Breakthroughs in labs remain prototypes unless governments, global institutions, and the private sector move together to deploy them at scale.
Innovation, in isolation, is inert. For technology to genuinely deliver “healthcare for all,” it must be carried on a robust scaffold of inclusive systems, earned trust, and equitable access. The tool is only as transformative as the foundation we build for it.
Wrapping up
Davos 2026 signaled that the healthcare industry has matured.
It’s no longer about what AI can do; It’s about how to pay for it, who owns the data, and how it integrates into data privacy and security.
Technology must now prove its measurable, real-world value. The market is looking for resilience, auditability, and scale. The hype is dead; the era of Health Intelligence has begun.
-By Alkama Sohail and the AHT Team
